The Medicine Maker | The Medicine Maker

How Pfizer and Lokavant are Transforming Trials with AI

July 15, 2025

We interview Pfizer and Lokavant about their partnership and why AI is the future of clinical trials.

9 min read

Lawsuit Launched Over COVID-19 Vaccine Schedule

Coalition of medical societies challenges federal directive that removed COVID-19 vaccines from key CDC immunization schedules.

Drug Discovery

AbbVie’s Eleni Lagkadinou on the Future of Cancer

What comes next for cancer drug development? AbbVie’s Eleni Lagkadinou discusses precision, AI, and her hope for turning cancer into a more chronic, manageable condition.

Industry News

This Week’s Biopharma News: Pfizer, BioNTech, and Moderna Court Case Continues

This week’s news roundup reports on MSD’s acquisition of Verona Pharma, Nipah virus treatment, and more.

Research News

Meet the RNA Coffee Machine

Researchers develop point-of-care device to produce personalized RNA medicines.

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Miguel Forte

President, ISCT and CEO, Kiji Therapeutics

View Profile

Claudia Zylberberg

Board Chair and Co-Founder, Kosten Digital; Board Chair and Co-Founder, Arscience Biotherapeutics; Foundation Board Member, Alliance for mRNA Medicines; Chair of the Board at Akron Bio

View Profile

From Wall Street to Cell Therapy: Audrey Greenberg’s Journey

We sit down with Audrey Greenberg to discuss investment, cell therapy, and what to look for when hiring talent.

Read the article

All the latest Medicine Maker articles.

Industry News Regulation & Standards

FDA Publishes Complete Response Letters

July 11, 2025

In an effort to increase transparency, the FDA has published letters sent to drug manufacturers after failing to secure approval

2 min read

Research News

This Week’s CGT News: Gene Therapy Restories Hearing

July 10, 2025

Our latest news roundup reports on stem cells taking on diabetes, genome surgery centers, and more.

4 min read

Business & Trends Formulation

Is The Generics Industry in Need of a Value Makeover?

July 10, 2025

The role of generic medicines in reducing costs, improving access, and saving lives.

4 min read

Development & Clinical

Why Don’t Turtles Get Cancer? A New Study Offers Clues

July 9, 2025

Turtles almost never get cancer. Researchers are looking into whether this fact could help us humans in the fight against the disease.

2 min read

Facilities & Equipment Sponsored

Bringing Velocity to Fill-Finish Lines

July 9, 2025

Find out how Corning^® Velocity^® vials can minimize flow disruptions, and improve efficiency and speed on fill-finish lines by reducing surface friction

3 min read

Bioprocessing

Heparin and the Lessons Learned

July 9, 2025

A look back on the history of one of healthcare’s mightiest molecules – and important lessons learned in supply chains and safety.

7 min read

Research News

Adjuvanted Vaccines Associated with Lower Dementia Risk

July 8, 2025

More evidence is emerging that vaccines may contribute to a lower risk of dementia.

3 min read

Industry News Drug Discovery

This Week’s Biopharma News: FDA Urged to Back Abortion Pill Mifepristone

July 8, 2025

Our latest news roundup reports on a malaria medicine for babies, EMA plasma manufacturing recommendations, nanomedicine for bladder cancer treatment, and more

4 min read

Drug Discovery Small Molecules

Can a Spider Venom-Inspired Peptide Revolutionize Sexual Dysfunction Medicine?

July 7, 2025

Another Day Pharma tells us how a spider venom-derived topical peptide might be able to help those affected by erectile dysfunction and female sexual dysfunction.

11 min read

Sitting Down With Development & Clinical

Making Solid Progress: Sitting Down With 2025 Power Lister John Maher

July 4, 2025

Following another appearance in our 2025 Power List, we discuss the journey of John Maher, co-founder and CSO, Leucid Bio, from Michel Sadelain’s New York lab to King’s College London.

5 min read

Top Stories